Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122836) titled 'Phase I and Phase II clinical trials of recombinant herpes zoster vaccine' on April 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hubei Center For Disease Control And Prevention
Condition:
Herpes Zoster
Intervention:
Phase I trial vaccine group 1:Vaccination
Phase I trial vaccine group 2:Vaccination
Phase I control group 2:Vaccination
Phase II trial vaccine group 2:Vaccination
Phase II trial vaccine group 1:Vaccination
Phase II positive control group:Vaccination
Phase I control group 4:Vaccination
Phase II placebo group:Vaccination
Phase I control group 1:Vaccination
Recrui...